These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6361804)

  • 1. Cellular pharmacokinetics of the phenylalanine mustards.
    Vistica DT
    Pharmacol Ther; 1983; 22(3):379-406. PubMed ID: 6361804
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
    Vistica DT; Ahmad S; Fuller R; Hill J
    Fed Proc; 1986 Sep; 45(10):2447-2450. PubMed ID: 3743787
    [No Abstract]   [Full Text] [Related]  

  • 3. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cytotoxicity of single dose and infusion of alkylating agents.
    Valeriote F; Vietti T
    Cancer Drug Deliv; 1985; 2(1):11-8. PubMed ID: 4052923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells.
    Vistica DT; Rabon A; Rabinovitz M
    Biochem Pharmacol; 1979 Nov; 28(21):3221-5. PubMed ID: 526327
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.
    Vistica DT
    Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of membrane transport of alkylating agents and amino acids by an analog of vasopressin in murine L5178Y lymphoblasts in vitro.
    Miller L; Kobrinsky NL; Goldenberg GJ
    Biochem Pharmacol; 1987 Jan; 36(1):169-76. PubMed ID: 3801052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
    Draeger U; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of resistance to alkylating agents of three ascites tumours in the rat.
    Poynter RW
    Biochem Pharmacol; 1970 Apr; 19(4):1387-97. PubMed ID: 4327763
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of labeled molecules in the pharmacokinetic study of alkylating agents (chlorambucil, melphalan, mitoclomine) and glycosyl nitrosoureas (RFCNU and RPCNU)].
    Meyniel G; Godenech D
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXIII-XXXV. PubMed ID: 545309
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
    Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258).
    Gravatt GL; Baguley BC; Wilson WR; Denny WA
    J Med Chem; 1994 Dec; 37(25):4338-45. PubMed ID: 7527862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of macromolecules as carriers of cytotoxic groups (part II) nitrogen mustard--protein complexes.
    Szekerke M; Wade R; Whisson ME
    Neoplasma; 1972; 19(3):211-5. PubMed ID: 5047465
    [No Abstract]   [Full Text] [Related]  

  • 17. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro.
    Martin AD; Beer RW; Bosanquet AG; Gilby ED
    Biochem Pharmacol; 1982 Sep; 31(17):2727-32. PubMed ID: 7138568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of tumor drug resistance].
    Kulik GI
    Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
    [No Abstract]   [Full Text] [Related]  

  • 20. Temperature dependence and effect of membrane lipid alteration on melphalan transport in L1210 murine leukemia cells.
    Burns CP; Dudley DT
    Biochem Pharmacol; 1982 Jun; 31(11):2116-9. PubMed ID: 7115429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.